Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 120709-09-3
2. (6r,7r)-7-amino-8-oxo-3-(1-propenyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
3. 107937-01-9
4. 7-apra
5. 4ze15v22rd
6. (6r,7r)-7-amino-8-oxo-3-((1e)-prop-1-enyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid
7. (6r,7r)-7-amino-8-oxo-3-[(e)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
8. 7-amino-8-oxo-3-((1e)-prop-1-enyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, (6r,7r)-
9. De(2-amino-2-(4-hydroxyphenyl)acetyl)cefprozil, (e)-
10. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-amino-8-oxo-3-(1e)-1-propen-1-yl-, (6r,7r)-
11. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-amino-8-oxo-3-(1e)-1-propenyl-, (6r,7r)-
12. (6r,7r)-7-amino-8-oxo-3-[(1e)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
13. Cefprozil Impurity F [ep]
14. Unii-4ze15v22rd
15. 7 Apra
16. Cefprozil Monohydrate Impurity F [ep]
17. Cefprozil Ep Impurity D
18. Cefprozil Ep Impurity F
19. (6r,7r)-7-amino-8-oxo-3-(1-propenyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carbo
20. Dtxsid20148332
21. Act05294
22. Amy27770
23. Bcp10063
24. Mfcd08458212
25. Zinc21992405
26. Akos015964988
27. Akos025149355
28. Ac-1879
29. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-amino-8-oxo-3-(1-propenyl)-, (6r-(3(e),6alpha,7beta))-
30. As-15055
31. Cefprozil Impurity F [ep Impurity]
32. H11004
33. 709a093
34. A892112
35. Cefprozil Monohydrate Impurity F [ep Impurity]
36. Q27260710
37. Cefprozil Related Compound D (e)-isomer [usp Impurity]
38. (6r,7r)-7-amino-8-oxo-3-(1-propenyl)-5-thia-1-azabicyclo [4. 2.0]oct-2--ene-2- Carboxylic Acid
39. (6r,7r)-7-amino-8-oxo-3-(1-propenyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid; Cefprozil Intermediate; Cefprozil Main-ring
40. (6r,7r)-7-amino-8-oxo-3-(prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid
41. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-amino-8-oxo-3-(1-propenyl)-, (6r-(3(e),6.alpha.,7.beta.))-
42. Cefprozil Usp Related Compound D; (6r,7r)-7-amino-8-oxo-3-[(1z)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
| Molecular Weight | 240.28 g/mol |
|---|---|
| Molecular Formula | C10H12N2O3S |
| XLogP3 | -2.5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 2 |
| Exact Mass | 240.05686342 g/mol |
| Monoisotopic Mass | 240.05686342 g/mol |
| Topological Polar Surface Area | 109 Ų |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 416 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
10
PharmaCompass offers a list of Molport-005-940-664 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Molport-005-940-664 manufacturer or Molport-005-940-664 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Molport-005-940-664 manufacturer or Molport-005-940-664 supplier.
PharmaCompass also assists you with knowing the Molport-005-940-664 API Price utilized in the formulation of products. Molport-005-940-664 API Price is not always fixed or binding as the Molport-005-940-664 Price is obtained through a variety of data sources. The Molport-005-940-664 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 7-APCA manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 7-APCA, including repackagers and relabelers. The FDA regulates 7-APCA manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 7-APCA API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 7-APCA supplier is an individual or a company that provides 7-APCA active pharmaceutical ingredient (API) or 7-APCA finished formulations upon request. The 7-APCA suppliers may include 7-APCA API manufacturers, exporters, distributors and traders.
7-APCA Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 7-APCA GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 7-APCA GMP manufacturer or 7-APCA GMP API supplier for your needs.
A 7-APCA CoA (Certificate of Analysis) is a formal document that attests to 7-APCA's compliance with 7-APCA specifications and serves as a tool for batch-level quality control.
7-APCA CoA mostly includes findings from lab analyses of a specific batch. For each 7-APCA CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
7-APCA may be tested according to a variety of international standards, such as European Pharmacopoeia (7-APCA EP), 7-APCA JP (Japanese Pharmacopeia) and the US Pharmacopoeia (7-APCA USP).
